About this trial

The goal of this open-label single-arm study is to test a meditative neurofeedback intervention for depressed mood.

Eligibility criteria

Qualifiers

moderate depression per PHQ9 symptom ratings

Disqualifiers

active substance abuse/dependence

psychotic disorders

bipolar disorder

displaying acutely suicidal behaviors

Trial design

Treatments tested in this trial

  • MediNF

Treatment groups

27 Participants
are divided into 1 treatment group

Locations

1
University of California San Diego92093, La JollaCalifornia, United States

Sponsors and collaborators

University of California, San Diego

Lead sponsor